? Buen Salario: R1.06/2024 2 Phd Positions. R1 Researchers (I-36)

Detalles de la oferta

R1.06/2024 2 PhD positions.
R1 Researchers (I-36)Nucleic acid-based therapies demonstrated their early success during the Covid-19 pandemic in 2020.
Nucleic acids are a valuable cargo that needs to be delivered, ideally, to a specific tissue or organ within the human body.
However, there are several challenges to achieve this effectively, and the use of nanocarriers is necessary.To work on these exciting challenges and receive interdisciplinary training in this area, we will be hiring PhD candidates with a background in chemistry, biology, physics, genetics, and material science.At CIPF, 2 positions are being offered for the development of 2 PhD theses:1.
DC12The Vicent Group recently identified polypeptide-based vectors targeting mitochondria.
In this PhD thesis, we will continue this research line, focusing on the design of bioresponsive, polypeptide-based polyplexes capable of targeting mitochondria and releasing selected cargoes through specific stimuli, such as reactive oxygen species (ROS) or other endogenous triggers.
We will develop hybrid polypeptide-polypeptoid copolymers incorporating a polyproline moiety.
These proline-rich moieties will be linked to the polyplexes, and their safety and transfection efficiency will be explored in cancer models.2.
DC14In close collaboration with Prof. Perrier at the University of Warwick and Prof. van Hest at the Technical University of Eindhoven (TUE), the PhD candidate will first develop a novel polymeric carrier capable of forming polyplexes and acting as a non-viral vector for gene transfection applications, seeking new therapeutic strategies against advanced solid tumors.
The PhD student will synthesize the polymeric nanocarriers at the University of Warwick, and subsequently at CIPF, will develop the derived polyplexes and validate them in in vitro and in vivo models of metastatic breast cancer.
The full characterization of the newly developed polyplexes will be carried out both at CIPF and during a secondment at the Technical University of Eindhoven (Prof. van Hest's lab).NATPRIME is a European project funded by the European Union's Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement no.
101168881.
It is also co-funded by the UK Guarantee Scheme.THE CV SHOULD REMOVE ALL PERSONAL REFERENCES: NAME, GENDER, AGE, MARITAL STATUS, NATIONALITY AND SHOULD NOT INCLUDE A PHOTOGRAPH.#J-18808-Ljbffr


Salario Nominal: A convenir

Fuente: Jobtome_Ppc

Requisitos

Senior Analyst, Clinical Research Systems & Reporting - A958

Analyst, Clinical Research Systems & Reporting - CRIO Home-based ICON plc is a world-leading healthcare intelligence and clinical research organization. We'r...


Ares Consultores - Madrid

Publicado 5 days ago

Dnp-127 | Manager, Amazon Ads, Adapt Rotational Management

Amazon Ads helps brands create experiences that delight customers and deliver meaningful results. With our first-party insights, 300+ million worldwide activ...


Ares Consultores - Madrid

Publicado 5 days ago

(Kp-983) Media Jornada Mañana Captador/A Cruz Roja 1.100€

Únete a nuestro equipo como captador/a de socios/as. ¡Buscamos a alguien como tú! que desprenda simpatía y dotes de comunicación en la calle, para motivar a ...


Ares Consultores - Madrid

Publicado 5 days ago

Clinical Research Associate (M/F/D) - Spain [Vhf762]

Location: Madrid or BarcelonaWho are we?Optimapharm is a leading, mid-sized, full-service CRO working across Europe and North America to deliver new therapie...


Ares Consultores - Madrid

Publicado 5 days ago

Built at: 2025-01-13T18:34:26.773Z